Potential for a more personalised approach to womb cancer

Manchester doctors have helped show that high-risk womb cancer patients can be genetically profiled to allow them to receive more appropriate treatment.

Traditionally, patients with – cancer of the womb lining - have their classified using a combination of clinical and tissue characteristics, including their age and the growth and invasion of their tumour.

Around 15-20% of patients have high-risk disease, but it is unclear what the best treatment approach is for these patients. Now Manchester researchers have investigated genetic alterations in high-risk endometrial cancer, to see if they could be used to create subtypes.

Professor Richard Edmondson, Professor of Gynaecological Oncology at The University of Manchester and Saint Mary's Hospital, said: "Previous work, using comprehensive genetic profiling, has suggested that endometrial cancer can be classified into four subtypes. Our study has explored whether it is possible to use a simpler approach to detect subgroups in high risk patients."

Using routinely available technology, the international TransPORTEC research consortium analysed samples from 116 patients with endometrial cancer to look for genetic variations.

The team, which also included Dr Emma Crosbie and Professor Henry Kitchener from Manchester, found that genetic subtypes existed in their group of patients, and that they could use their classification to predict which patients were more likely to relapse.

In addition, the analysis allowed them to identify distinctive genetic mutations that can be targeted with specific anti-cancer drugs.

"It looks like these cancers classed as 'high-risk' in fact vary significantly in outcome. Our results could be used to refine risk assessment for endometrial cancer patients and allow doctors to choose either a less aggressive approach or more targeted treatment for individual ," added Professor Edmondson.

Explore further

Profiling approach to enable right lung cancer treatment match

More information: "Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative" Stelloo et al. (2015) Modern Pathology Feb 27. DOI: 10.1038/modpathol.2015.43
Citation: Potential for a more personalised approach to womb cancer (2015, May 7) retrieved 20 August 2019 from https://medicalxpress.com/news/2015-05-potential-personalised-approach-womb-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more